These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1820 related items for PubMed ID: 28747369

  • 1. Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?
    Gao Y, Li Y, Meng Q, Zhang Z, Zhao P, Shang Q, Li Y, Su M, Li T, Liu X, Zhuang H.
    J Clin Microbiol; 2017 Oct; 55(10):2972-2982. PubMed ID: 28747369
    [Abstract] [Full Text] [Related]

  • 2. Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients.
    Wang L, Cao X, Wang Z, Gao Y, Deng J, Liu X, Zhuang H.
    J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30355757
    [Abstract] [Full Text] [Related]

  • 3. Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment.
    Wang X, Chi X, Wu R, Xu H, Gao X, Yu L, Liu L, Zhang M, Tan Y, Niu J, Jin Q.
    Virol J; 2021 Jan 06; 18(1):4. PubMed ID: 33407619
    [Abstract] [Full Text] [Related]

  • 4. Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy.
    Li J, Sun X, Fang J, Wang C, Han G, Ren W.
    Clin Res Hepatol Gastroenterol; 2017 Dec 06; 41(6):635-643. PubMed ID: 28438570
    [Abstract] [Full Text] [Related]

  • 5. Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency.
    Wong DK, Seto WK, Fung J, Ip P, Huang FY, Lai CL, Yuen MF.
    Clin Gastroenterol Hepatol; 2013 Aug 06; 11(8):1004-10.e1. PubMed ID: 23376799
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg-positive and HBeAg-negative chronic hepatitis B.
    Chuaypen N, Sriprapun M, Praianantathavorn K, Payungporn S, Wisedopas N, Poovorawan Y, Tangkijvanich P.
    J Med Virol; 2017 Jan 06; 89(1):130-138. PubMed ID: 27307409
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum HBV DNA plus RNA reflecting cccDNA level before and during NAs treatment in HBeAg positive CHB patients.
    Wang Y, Liu Y, Liao H, Deng Z, Bian D, Ren Y, Yu G, Jiang Y, Bai L, Liu S, Liu M, Zhou L, Chen Y, Chen X, Duan Z, Lu F, Zheng S.
    Int J Med Sci; 2022 Jan 06; 19(5):858-866. PubMed ID: 35693741
    [Abstract] [Full Text] [Related]

  • 10. Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA.
    Chen EQ, Wang ML, Tao YC, Wu DB, Liao J, He M, Tang H.
    J Viral Hepat; 2019 May 06; 26(5):586-595. PubMed ID: 30632235
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
    Manesis EK, Papatheodoridis GV, Tiniakos DG, Hadziyannis ES, Agelopoulou OP, Syminelaki T, Papaioannou C, Nastos T, Karayiannis P.
    J Hepatol; 2011 Jul 06; 55(1):61-8. PubMed ID: 21145875
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals.
    Huang H, Wang J, Li W, Chen R, Chen X, Zhang F, Xu D, Lu F.
    J Clin Virol; 2018 Jul 06; 99-100():71-78. PubMed ID: 29353073
    [Abstract] [Full Text] [Related]

  • 14. Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients.
    García-López M, Lens S, Pallett LJ, Testoni B, Rodríguez-Tajes S, Mariño Z, Bartres C, García-Pras E, Leonel T, Perpiñán E, Lozano JJ, Rodríguez-Frías F, Koutsoudakis G, Zoulim F, Maini MK, Forns X, Pérez-Del-Pulgar S.
    J Hepatol; 2021 May 06; 74(5):1064-1074. PubMed ID: 33278456
    [Abstract] [Full Text] [Related]

  • 15. Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B.
    Lai CL, Wong D, Ip P, Kopaniszen M, Seto WK, Fung J, Huang FY, Lee B, Cullaro G, Chong CK, Wu R, Cheng C, Yuen J, Ngai V, Yuen MF.
    J Hepatol; 2017 Feb 06; 66(2):275-281. PubMed ID: 27639844
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA.
    Wong DK, Seto WK, Cheung KS, Chong CK, Huang FY, Fung J, Lai CL, Yuen MF.
    Liver Int; 2017 Jul 06; 37(7):995-1001. PubMed ID: 27992681
    [Abstract] [Full Text] [Related]

  • 17. Differential HBV replicative markers and covalently closed circular DNA transcription in immune-active chronic hepatitis B with and without HBeAg.
    Kim HS, Kim JS, Kim JM, Han JW, Lee SK, Nam H, Sung PS, Kwon JH, Bae SH, Choi JY, Yoon SK, Jang JW.
    Liver Int; 2024 Oct 06; 44(10):2753-2762. PubMed ID: 39073214
    [Abstract] [Full Text] [Related]

  • 18. Predictive value of intrahepatic hepatitis B virus covalently closed circular DNA and total DNA in patients with acute hepatitis B and patients with chronic hepatitis B receiving anti‑viral treatment.
    Ruan P, Zhou B, Dai X, Sun Z, Guo X, Huang J, Gong Z.
    Mol Med Rep; 2014 Apr 06; 9(4):1135-41. PubMed ID: 24566465
    [Abstract] [Full Text] [Related]

  • 19. Effects of entecavir on hepatitis B virus covalently closed circular DNA in hepatitis B e antigen-positive patients with hepatitis B.
    Shi M, Sun WL, Hua YY, Han B, Shi L.
    PLoS One; 2015 Apr 06; 10(2):e0117741. PubMed ID: 25647607
    [Abstract] [Full Text] [Related]

  • 20. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.
    Thompson AJ, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M, Slavin J, Bowden S, Gane EJ, Abbott W, Lau GK, Lewin SR, Visvanathan K, Desmond PV, Locarnini SA.
    Hepatology; 2010 Jun 06; 51(6):1933-44. PubMed ID: 20512987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 91.